COPART vs ORGO
COPART (COPART) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
COPART does not have a complete income-statement cache yet.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
ORGO currently screens at market cap $301.1M.
Not investment advice. Open the COPART and ORGO stock pages for the full models.
Not investment advice.